NCT07284459Phase 2Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Study sponsor: Contineum Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-05Estimated
Enrollment · participants324Estimated
Source updated2026-11-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source